Three different missense mutations were found in other genome or exome sequencing studies, making DLEC1 a candidate tumor suppressor gene in cutaneous melanoma, probably acting by inhibition of cell proliferation [12, 13]. This evidence concerns the gene DLEC1 and cutaneous melanoma.